95th General Assembly, 1st Regular Session

HB 1149

  
Requires health benefit plans to provide coverage on equal terms for intravenous or injected cancer medications and orally administered anticancer medications as a pharmaceutical benefit
Sponsor: Deeken, Bill (114)
Proposed Effective Date: 8/28/2009
LR Number: 2504L.01I
Last Action: 05/15/2009 - Referred: Special Standing Committee on Health Insurance (H) Urban Issues(H)
Bill String: HB 1149
Next House Hearing: Hearing not scheduled
Calendar: Bill currently not on a House calendar

Bill Text

2504L.01I

Bill Summary

Bill Summary
HB1149I